Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Questioning imiquimod's impact on scars
National report - Best known as the modern-day defender against basal cell carcinoma and actinic keratoses, imiquimod 5 percent cream (Aldara) is also gaining a reputation for its biosynthetic and clinical results in the treatment of scars - and evidence continues to mount supporting the immune response modifier's prominence in repealing one of the most notorious of scars: keloids.
Related Videos
Related Content
